Physician profile
Eric R Emanuel
NPI 1609868983
$7,806.89
in general payments reported to CMS, 2019-2025
37 companies · $5,006 in 2025
The $5,006 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $687 · 2020: $67.45 · 2021: $151 · 2022: $227 · 2023: $1,153 · 2024: $516 · 2025: $5,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,180 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Travel and Lodging: $1,898 · Debt Forgiveness: $561 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,180.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Travel and Lodging | $1,897.58 |
| Debt Forgiveness | $561.24 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avyxa Pharma, LLC | $4,413.80 | 2025 | |
| Olympus America INC. | $585.97 | 2023 | Cysto-Nephro Videoscope, Itind System |
| Janssen Biotech, INC. | $307.20 | 2019-2024 | Erleada, Akeega |
| Astellas Pharma US INC | $296.90 | 2019-2023 | Myrbetriq |
| Endo USA, INC. | $195.01 | 2024-2025 | Xiaflex, Aveed, Edex |
| Dendreon Pharmaceuticals LLC | $171.57 | 2019-2024 | Provenge |
| Sumitomo Pharma America, INC. | $167.72 | 2023-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $149.51 | 2019-2023 | |
| Axonics, INC. | $123.53 | 2022-2024 | Axonics |
| Pfizer INC. | $122.63 | 2019-2023 | |
| Urogen Pharma, INC. | $121.49 | 2023-2025 | Jelmyto |
| Immunitybio, INC. | $119.30 | 2025 | |
| Telix Pharmaceuticals | $104.22 | 2024-2025 | Illuccix |
| Boston Scientific Corporation | $87.44 | 2019-2025 | Ams 800 Artificial Urinary Sphincter |
| Coloplast Corp | $81.56 | 2023-2024 | Titan |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $72.16 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $69.16 | 2025 | |
| Myovant Sciences INC. | $63.00 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $44.69 | 2019-2024 | Adstiladrin |
| Zyla Life Sciences, INC. | $43.23 | 2019 | |
| Halozyme INC | $41.02 | 2023 | |
| Progenics Pharmaceuticals, INC. | $39.96 | 2023-2025 | Pylarify |
| Blue Earth Diagnostics | $38.84 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Janssen Pharmaceuticals, INC | $34.50 | 2019-2025 | Erleada |
| Urovant Sciences INC | $34.31 | 2022 | |
| Teleflex LLC | $33.80 | 2024 | Solesta |
| Civco Medical Instruments | $31.68 | 2024 | |
| Verity Pharmaceuticals INC. | $29.31 | 2025 | Trelstar |
| Skeletal Dynamics INC | $25.54 | 2023 | Ijs, Geminus, Align |
| Amgen INC. | $22.75 | 2021 | |
| Medtronic, INC. | $20.73 | 2024 | Interstim |
| Allergan, INC. | $18.36 | 2019 | |
| Antares Pharma, INC. | $17.10 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.07 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $13.50 | 2019 | |
| Laborie Medical Technologies Corp. | $13.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Emanuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.